MSN: Levemir® discontinuation

Levemir® products are being discontinued. Stock exhaustion is expected in December 2026.

The affected lines are:

Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens
Levemir® (insulin detemir) Penfill® 100units/ml solution for injection 3ml cartridges

Up-to-date information on medicines supply shortages is available via the online SPS Medicines Supply Tool.

Supply Shortages

Latest news

England & Wales: initial August concession price update

The Department of Health and Social Care has published an initial update to the initial list of August concessions. In this update, there are 48 new prices DDA members can download a fully updated spreadsheet of the Aug

New CD guidance for limited companies

The DDA and the Healthcare Distribution Association (HDA) has published joint guidance on the supply of Controlled Drugs to GP practices constituted as a limited company. In summary, two core regulatory requirements apply: Care regulator registra

Dispensing cross subsidy highlighted in rural GP funding critique

The role of dispensing income as a cross subsidy for rural NHS GP funding has been highlighted in a new paper by a think-tank. Noting the funding challenges of delivering NHS GP services in rural areas, General practice funding in England publ

MSN: Levemir® discontinuation

Latest news

England & Wales: initial August concession price update

New CD guidance for limited companies

Dispensing cross subsidy highlighted in rural GP funding critique

View all news

Gold Supporters

Follow us

Dispensing Doctors' Association

DDA Best Practice Group

Dispensing Doctors' Association